Outlook Therapeutics to Present at the April 2020 Virtual Investor Summit
CRANBURY, N.J., April 15, 2020 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (NASDAQ: OTLK) (the “Company”), a late clinical-stage biopharmaceutical company working to develop […]